Related Experiment Video
Updated: Jul 25, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Drug Interactions with Antiretrovirals
1247 Cooke Hall, Laboratory for Antiviral Research, Department of Pharmacy Practice, State University of New York at Buffalo, Amherst, NY 14260, USA. emorse@acsu.buffalo.edu
Current Infectious Disease Reports
|November 30, 2000
Summary
New antiretroviral drugs and combination regimens for HIV increase the importance of drug-drug interactions. Understanding pharmacokinetic mechanisms, like P-glycoprotein and cytochrome P450, is crucial for managing these interactions in HIV care.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Advancements in antiretroviral therapy (ART) involve multi-drug regimens for optimal HIV suppression.
- The increasing complexity of ART highlights the clinical significance of drug-drug interactions (DDIs).
Purpose of the Study:
- To underscore the importance of understanding pharmacokinetic drug-drug interactions in HIV management.
- To discuss the physiological mechanisms complicating the interpretation of DDIs in HIV-infected individuals.
Main Methods:
- Review of current antiretroviral drug development and clinical practices.
- Examination of pharmacokinetic mechanisms, including drug transporters and metabolic enzymes.
Main Results:
- The use of potent combination antiretroviral therapy necessitates careful consideration of DDIs.
- Expanding knowledge of drug transport (e.g., P-glycoprotein) and hepatic metabolism (e.g., cytochrome P450) influences DDI interpretation.
Conclusions:
- Effective management of HIV requires a thorough understanding of drug-drug interactions.
- Physiological mechanisms of pharmacokinetic interactions are key to interpreting and managing DDIs in HIV treatment.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...